PURPOSE: Whether neoadjuvant chemotherapy safely allows close margins in osteosarcoma patients is still unknown. This study investigates the impact of close margins on local recurrence (LR) and overall survival (OS) for osteosarcoma patients treated with neoadjuvant chemotherapy. METHODS: We retrospectively reviewed 47 cases of conventional osteosarcoma who were treated at our institution. Patient and treatment factors such as age, gender, MSTS stage, tumour site, surgery type, pathological type, tumour size, surgical margin, tumour necrosis rate, chemotherapy regimens and cycles were recorded. A close margin was defined as tumour present less than 5 mm from the closest resection margin. The average followup was 87.6 months (range, 25-135 months). RESULTS: Twenty-five patients were alive, 22 patients had died, and eight had LR. Twenty-eight patients had wide margins, seven had positive margins and 12 had close margins. Positive margins had a greater risk of LR (57.1%) than wide margins and close margins. There was no difference in LR (8.3% vs 10.7%) between close margins and wide margins. Margin status was not correlated with OS. CONCLUSION: Compared with wide margins, close margins did not lead to increased local recurrence in our study group. Whether close margins, as defined in our study, are just as acceptable as wide margins in terms of patient outcomes for osteosarcoma patients with neoadjuvant chemotherapy needs to be further confirmed in the future.
PURPOSE: Whether neoadjuvant chemotherapy safely allows close margins in osteosarcomapatients is still unknown. This study investigates the impact of close margins on local recurrence (LR) and overall survival (OS) for osteosarcomapatients treated with neoadjuvant chemotherapy. METHODS: We retrospectively reviewed 47 cases of conventional osteosarcoma who were treated at our institution. Patient and treatment factors such as age, gender, MSTS stage, tumour site, surgery type, pathological type, tumour size, surgical margin, tumour necrosis rate, chemotherapy regimens and cycles were recorded. A close margin was defined as tumour present less than 5 mm from the closest resection margin. The average followup was 87.6 months (range, 25-135 months). RESULTS: Twenty-five patients were alive, 22 patients had died, and eight had LR. Twenty-eight patients had wide margins, seven had positive margins and 12 had close margins. Positive margins had a greater risk of LR (57.1%) than wide margins and close margins. There was no difference in LR (8.3% vs 10.7%) between close margins and wide margins. Margin status was not correlated with OS. CONCLUSION: Compared with wide margins, close margins did not lead to increased local recurrence in our study group. Whether close margins, as defined in our study, are just as acceptable as wide margins in terms of patient outcomes for osteosarcomapatients with neoadjuvant chemotherapy needs to be further confirmed in the future.
Authors: G Bacci; A Briccoli; S Ferrari; A Longhi; M Mercuri; R Capanna; D Donati; S Lari; C Forni; M DePaolis Journal: Eur J Cancer Date: 2001-11 Impact factor: 9.162
Authors: S Ferrari; G Bacci; P Picci; M Mercuri; A Briccoli; D Pinto; A Gasbarrini; A Tienghi; A Brach del Prever Journal: Ann Oncol Date: 1997-08 Impact factor: 32.976
Authors: Bruno Fuchs; Nathan Hoekzema; Dirk R Larson; Carrie Y Inwards; Franklin H Sim Journal: Clin Orthop Relat Res Date: 2008-10-15 Impact factor: 4.176
Authors: G Bacci; S Ferrari; A Longhi; S Perin; C Forni; N Fabbri; N Salduca; M Versari; K V Smith Journal: Eur J Cancer Date: 2001-01 Impact factor: 9.162
Authors: Remco de Bree; Paul van der Valk; Dirk J Kuik; Paul J van Diest; Patricia Doornaert; Jan Buter; Simone E J Eerenstein; Johannes A Langendijk; Isaäc van der Waal; C René Leemans Journal: Oral Oncol Date: 2006-03-10 Impact factor: 5.337
Authors: Matthew J Thompson; John C Shapton; Stephanie E Punt; Christopher N Johnson; Ernest U Conrad Journal: Clin Orthop Relat Res Date: 2018-03 Impact factor: 4.176
Authors: Philippe Hernigou; Charles Henri Flouzat Lachaniette; Jerome Delambre; Nathalie Chevallier; Helene Rouard Journal: Int Orthop Date: 2014-06-07 Impact factor: 3.075
Authors: Christoph J Laux; Gundula Berzaczy; Michael Weber; Susanna Lang; Martin Dominkus; Reinhard Windhager; Iris-Melanie Nöbauer-Huhmann; Philipp T Funovics Journal: Int Orthop Date: 2014-11-30 Impact factor: 3.075
Authors: Amos H P Loh; Huiyun Wu; Armita Bahrami; Fariba Navid; M Beth McCarville; Chong Wang; Jianrong Wu; Michael W Bishop; Najat C Daw; Michael D Neel; Bhaskar N Rao Journal: Pediatr Blood Cancer Date: 2014-11-08 Impact factor: 3.167
Authors: Tom Cosker; Philipp Lechler; Aashish Gulati; Duncan Whitwell; Hank Giele; Sally Trent; Nick Athanasou; Christopher Gibbons Journal: Int Orthop Date: 2014-06-20 Impact factor: 3.075